BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

BrainsWay Ltd.

Brainsway ( ($BWAY) ) has provided an announcement. On July 20, 2026, BrainsWay announced a $3 million minority equity investment in Radial Health ...

BrainsWay Invests $3 Million in Radial Health to Expand Access to Brain Medicine Clinics

The latest announcement is out from Brainsway ( ($BWAY) ). On July 16, 2026, BrainsWay announced a $500,000 minority-stake investment in Sound Mind...

BrainsWay Takes Minority Stake in Sound Minds Behavioral to Expand Interventional Psychiatry Reach

Brainsway ( ($BWAY) ) has shared an update. On June 29, 2026, BrainsWay reported new real-world data from what it described as the largest analysis...

BrainsWay Unveils Strong Real-World Deep TMS Data in Comorbid PTSD and Depression

Brainsway ( ($BWAY) ) has shared an update. On June 22, 2026, BrainsWay reported that favorable insurance coverage for its SWIFT Accelerated Deep T...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BWAY	$16.50	+4.90%	323.67K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BWAY	$16.50	+4.9%	323.67K
3
4
5
6

BWAY

BWAY

Get BrainsWay Ltd. Data in Excel

Get BrainsWay Ltd. Data in Excel